Concepedia

Kristy Iglay

KI

Statistics

Publications

18

Citations

1.3K

H-Index

15

Active since

2014

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Kantar Health (United States)

University College London

Optum (United States)

The University of Tokyo

Kristy Iglay is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, diabetes, and public health.

ORCID

Top concepts

Publications per year

2014–2022

18

Publications

18

Prevalence and co-prevalence of comorbidities among patients with type 2 diabetes mellitus

Kristy Iglay, Hakima Hannachi, Patrick Joseph Howie et al. · Current Medical Research and Opinion · 2016 · 488 citations

Real-world weight change, adherence, and discontinuation among patients with type 2 diabetes initiating glucagon-like peptide-1 receptor agonists in the UK

Tracey Weiss, Lingfeng Yang, Richard D. Carr et al. · BMJ Open Diabetes Research & Care · 2022 · 128 citations · Full text

<p>Real-World Adherence and Discontinuation of Glucagon-Like Peptide-1 Receptor Agonists Therapy in Type 2 Diabetes Mellitus Patients in the United States</p>

Tracey Weiss, Richard D. Carr, Sampriti Pal et al. · Patient Preference and Adherence · 2020 · 99 citations · Full text

Risk characterization for urinary tract infections in subjects with newly diagnosed type 2 diabetes

Alex Z. Fu, Kristy Iglay, Ying Qiu et al. · Journal of Diabetes and its Complications · 2014 · 83 citations · Full text

Impact of Preexisting Mental Illness on All-Cause and Breast Cancer–Specific Mortality in Elderly Patients With Breast Cancer

Kristy Iglay, Melissa L. Santorelli, Kim M. Hirshfield et al. · Journal of Clinical Oncology · 2017 · 81 citations

, , +21

1–5 of 18